The Key to Successful Antimicrobial Stewardship: Interdisciplinary Teams
Title: The Key to Successful Antimicrobial Stewardship: Interdisciplinary Teams
Date: Wednesday, January 22
Time: 1 p.m. ET
Presenters: James A. McKinnell, MD
Moving Beyond Low-Hanging Fruit
While new antibiotic development has slowed, antimicrobial resistance is on the rise. The development of multi-drug resistant microorganisms (MDRO) has led to complicated infections that are difficult to manage. The aim of antimicrobial stewardship programs is to promote the appropriate use of antimicrobials to improve patient outcomes, reduce microbial resistance, and decrease the spread of MDRO infections.
Managing multi-drug resistance is particularly challenging for institutions when MDROs are transmitted to vulnerable patient populations. The few available therapeutic options can be limited by toxicity that may further compromise patients. We need to find accurate diagnostic tools that can direct us to the most appropriate clinical treatments for these life-threatening infections.
In this P.A.C.E.-accredited Fisher Healthcare webinar, James A. McKinnell, MD, will discuss how antimicrobial susceptibility platforms that include novel drugs and drugs of last resort can lead to more effective treatment decisions, reduce length of stay, and improve patient outcomes.
This webinar will help you:
- Explain a challenging case from the perspective of a clinical laboratory
- Evaluate testing options for the rapid identification of resistant infections
- Demonstrate the need for new therapeutics to accompany accurate diagnostics
This webinar is produced by Whitehat Communications, a provider of continuing education programs in clinical laboratory sciences that has been approved by the ASCLS P.A.C.E.™ Program. One P.A.C.E. credit hour will be provided for this complimentary, basic-level program.
James A. McKinnell, MD
Dr. McKinnell is an Assistant Professor of Medicine in the David Geffen School of Medicine at the University of California, Los Angeles. He is also a member of the Infectious Disease Clinical Outcome Research Unit (ID-CORE) and the Los Angeles Biomedical Research Institute at Harbor-UCLA.
McKinnell is a nationally recognized infectious disease specialist with specific research interests related to the clinical management and prevention of healthcare-associated infections. He has published more than 40 papers, many of which emphasize antimicrobial resistance within the community and the optimal use of antibiotics.